[go: up one dir, main page]

SE0602414L - Nya formuleringar för behandling av olika inflammatoriska sjukdomar - Google Patents

Nya formuleringar för behandling av olika inflammatoriska sjukdomar

Info

Publication number
SE0602414L
SE0602414L SE0602414A SE0602414A SE0602414L SE 0602414 L SE0602414 L SE 0602414L SE 0602414 A SE0602414 A SE 0602414A SE 0602414 A SE0602414 A SE 0602414A SE 0602414 L SE0602414 L SE 0602414L
Authority
SE
Sweden
Prior art keywords
treatment
inflammatory diseases
various inflammatory
new formulations
formulations
Prior art date
Application number
SE0602414A
Other languages
English (en)
Other versions
SE532249C2 (sv
Inventor
Lars Hellman
Original Assignee
Theravac Pharmaceuticals Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravac Pharmaceuticals Ab filed Critical Theravac Pharmaceuticals Ab
Priority to SE0602414A priority Critical patent/SE532249C2/sv
Priority to EP07835198A priority patent/EP2091562A4/en
Priority to RU2009119925/15A priority patent/RU2009119925A/ru
Priority to CA002668764A priority patent/CA2668764A1/en
Priority to US12/312,488 priority patent/US20100203008A1/en
Priority to AU2007320149A priority patent/AU2007320149A1/en
Priority to PCT/SE2007/000998 priority patent/WO2008060219A1/en
Priority to JP2009536199A priority patent/JP2010509321A/ja
Publication of SE0602414L publication Critical patent/SE0602414L/sv
Publication of SE532249C2 publication Critical patent/SE532249C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE0602414A 2006-11-13 2006-11-13 Nya formuleringar av IL-18 för behandling av olika inflammatoriska sjukdomar genom vaccinering SE532249C2 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE0602414A SE532249C2 (sv) 2006-11-13 2006-11-13 Nya formuleringar av IL-18 för behandling av olika inflammatoriska sjukdomar genom vaccinering
EP07835198A EP2091562A4 (en) 2006-11-13 2007-11-12 IL-18 VACCINE FOR THE TREATMENT OF VARIOUS INFLAMMATORY DISEASES
RU2009119925/15A RU2009119925A (ru) 2006-11-13 2007-11-12 Il-18 вакцина для лечения различных воспалительных состояний
CA002668764A CA2668764A1 (en) 2006-11-13 2007-11-12 Novel compositions for the treatment of various inflammatory conditions
US12/312,488 US20100203008A1 (en) 2006-11-13 2007-11-12 Novel compositions for the treatment of verious inflammatory conditions
AU2007320149A AU2007320149A1 (en) 2006-11-13 2007-11-12 IL- 18 vaccine for the treatment of various inflammatory conditions.
PCT/SE2007/000998 WO2008060219A1 (en) 2006-11-13 2007-11-12 Il- 18 vaccine for the treatment of various inflammatory conditions.
JP2009536199A JP2010509321A (ja) 2006-11-13 2007-11-12 種々の炎症状態の治療用の新規な組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0602414A SE532249C2 (sv) 2006-11-13 2006-11-13 Nya formuleringar av IL-18 för behandling av olika inflammatoriska sjukdomar genom vaccinering

Publications (2)

Publication Number Publication Date
SE0602414L true SE0602414L (sv) 2008-05-14
SE532249C2 SE532249C2 (sv) 2009-11-24

Family

ID=39401936

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0602414A SE532249C2 (sv) 2006-11-13 2006-11-13 Nya formuleringar av IL-18 för behandling av olika inflammatoriska sjukdomar genom vaccinering

Country Status (8)

Country Link
US (1) US20100203008A1 (sv)
EP (1) EP2091562A4 (sv)
JP (1) JP2010509321A (sv)
AU (1) AU2007320149A1 (sv)
CA (1) CA2668764A1 (sv)
RU (1) RU2009119925A (sv)
SE (1) SE532249C2 (sv)
WO (1) WO2008060219A1 (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2952750B2 (ja) * 1995-02-23 1999-09-27 株式会社林原生物化学研究所 モノクローナル抗体
AU3827699A (en) * 1998-05-07 1999-11-23 Akzo Nobel N.V. Use of interleukin-18 as vaccine adjuvant
US6846486B1 (en) * 2000-02-24 2005-01-25 Advanced Biotherapy Concepts, Inc. Method of treating allergy by administering an anti-histamine antibody
AU2001245414A1 (en) * 2000-03-10 2001-09-24 The Board Of Trustees Of Leland Stanford Junior University Treatment of allergies
AU2002224417A1 (en) * 2000-10-18 2002-04-29 Immunex Corporation Methods for treating il-18 mediated disorders
KR20030012199A (ko) * 2001-07-31 2003-02-12 (주)지노첵 사이토카인 유전자를 유효성분으로 포함하는 ｄｎａ 백신
WO2003057821A2 (en) * 2001-10-26 2003-07-17 Centocor, Inc. Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
EP1534323A2 (en) * 2002-08-30 2005-06-01 Glaxo Group Limited Il-14 vaccine for the treatment of asthma and atopic disorders
CU23093A1 (es) * 2002-10-09 2005-10-19 Ct Ingenieria Genetica Biotech Composición vacunal que comprende interleucina-15 (il-15)
US7569552B2 (en) * 2003-10-08 2009-08-04 The Scripps Research Institute DNA vaccines against tumor growth and methods of use therof
GB0323968D0 (en) * 2003-10-13 2003-11-19 Glaxosmithkline Biolog Sa Immunogenic compositions

Also Published As

Publication number Publication date
US20100203008A1 (en) 2010-08-12
CA2668764A1 (en) 2008-05-22
JP2010509321A (ja) 2010-03-25
WO2008060219A1 (en) 2008-05-22
AU2007320149A1 (en) 2008-05-22
RU2009119925A (ru) 2010-12-20
EP2091562A4 (en) 2010-04-07
SE532249C2 (sv) 2009-11-24
EP2091562A1 (en) 2009-08-26

Similar Documents

Publication Publication Date Title
DK2474321T3 (da) Sammensætninger til behandling af collagenmedierede sygdomme
EP1996612A4 (en) COMPOSITIONS FOR THE TREATMENT OF CANCER
NO20090596L (no) Antivirale fosfinatforbindelser
LT2478907T (lt) Kompozicijos vėžiui gydyti
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
EA201270575A1 (ru) Соединения
EA201200551A1 (ru) Фармацевтическая композиция, фармацевтическая дозированная форма, способы их получения и применения для лечения
MX2009006704A (es) Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa.
DK2419114T4 (da) Bakteriesammensætninger til profylakse og behandling af degenerative sygdomme
EA201170832A1 (ru) Пуриновые соединения
EA201170521A1 (ru) Новые соединения
UA107188C2 (uk) Карбоксамідні похідні хіназолінів або хінолінів та фармацевтична композиція на їх основі
EA200900213A1 (ru) Ингибиторы обратной транскриптазы вич (варианты), фармацевтическая композиция на их основе, способ ингибирования репликации ретровируса с их помощью и названные ингибиторы для изготовления лекарственного средства для ингибирования обратной транскриптазы вич и для лечения или профилактики инфекционного вич
CR9347A (es) Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos
EA201171435A1 (ru) Твердые фармацевтические композиции и способы их получения
GEP20186885B (en) Novel compounds
ATE489371T1 (de) Benzamidglucokinaseaktivatoren
EP2135858A4 (en) COMPOSITION FOR TREATING INFECTIOUS DISEASES
ATE544759T1 (de) 5-pyridinon-substituierte indazole und pharmazeutische zusammensetzungen davon
UA107183C2 (uk) Феніламіно-ізонікотинамідні сполуки, їх застосування, фармацевтична композиція, що їх містить, та спосіб лікування гіперпроліферативних захворювань
MY174797A (en) Anti-inflammatory compositions
EP2528440A4 (en) SUBSTITUTED NORINDEN ISOCHINOLINE, SYNTHESIS THEREOF AND METHOD OF USE THEREOF
ATE474574T1 (de) Imidazoazephinonverbindungen
SE0602550L (sv) Nya formuleringar för behandling av TH2 medierade inflamatoriska sjukdomar
TR201002878A2 (tr) Sefpodoksim proksetil içeren farmasötik bileşimler.

Legal Events

Date Code Title Description
NUG Patent has lapsed